Document is current
Any future updates will be listed below
-
Authors
Young, Paul J. https://orcid.org/0000-0002-3428-3083
Bellomo, Rinaldo
Bernard, Gordon R.
Niven, Daniel J.
Schortgen, Frederique
Saxena, Manoj
Beasley, Richard
Weatherall, Mark
-
Funding
Funding for this research was provided by:
Health Research Council of New Zealand (Clinical Practitioner Fellowship)
- License Information
-
More Information
Article History
Received: 6 December 2018
Accepted: 29 January 2019
First Online: 11 February 2019
Compliance with ethical standards
:
: Dr. Paul Young and Dr. Manoj Saxena report receiving speaker’s fees from Bard Medical Pty. Dr. Gordon Bernard reports having an equity stake and is on the Board of Directors for Cumberland Pharmaceuticals, Nashville, TN, makers of intravenous ibuprofen (Caldolor).
: An approval by an ethics committee was not applicable.
